PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine
Status:
Terminated
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
To determine the overall safety of PF-00477736 when given in combination with gemcitabine, a
chemotherapy agent, in patients with advanced solid tumors and determine the maximum dose of
PF-00477736 that can be safely given in combination with gemcitabine. This is the first study
of PF-00477736 in humans.